Sartorius Stedim Biotech (CHIX:DIMP) Land And Improvements: €0 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CHIX:DIMP Sartorius Stedim Biotech SA CHIX:DIMP
80 GF Score
Price €193.00
GF Value €202.60
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is Sartorius Stedim Biotech Land And Improvements?

Sartorius Stedim Biotech CHIX:DIMP 80 Land And Improvements is €0 Mil as of Jun. 2026. GuruFocus rates CHIX:DIMP with a GF Score™ of 80/100 and a GF Value™ of €202.60 (Fairly Valued). The stock has 5 warning signs investors should review.

Sartorius Stedim Biotech's land and improvements for the quarter that ended in Jun. 2026 was €0 Mil.

Sartorius Stedim Biotech's quarterly land and improvements declined from Dec. 2025 (€1,023 Mil) to Mar. 2026 (€0 Mil) but then stayed the same from Mar. 2026 (€0 Mil) to Jun. 2026 (€0 Mil).

Sartorius Stedim Biotech's annual land and improvements increased from Dec. 2023 (€708 Mil) to Dec. 2024 (€803 Mil) and increased from Dec. 2024 (€803 Mil) to Dec. 2025 (€1,023 Mil).

Sartorius Stedim Biotech Land And Improvements Historical Data

* Premium members only.

The historical data trend for Sartorius Stedim Biotech's Land And Improvements can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sartorius Stedim Biotech Land And Improvements Chart

Sartorius Stedim Biotech Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Land And Improvements
Get a 7-Day Free Trial Premium Member Only Premium Member Only 426.20 509.09 708.00 803.00 1,023.40

Sartorius Stedim Biotech Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Land And Improvements Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 1,023.40 0.00 0.00
CHIX:DIMP
80GF Score
Sartorius Stedim Biotech SA CHIX:DIMP
Land And Improvements is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sartorius Stedim Biotech Land And Improvements Calculation

Land is the surface or crust of the earth, which can be used to support structures, and may be used to grow crops, grass, shrubs, and trees. Land is characterized as having an unlimited life (indefinite). Land improvement is a long-term asset which indicates the cost of the constructed improvements to land, such as driveways, walkways, lighting, and parking lots.

Frequently Asked Questions Learn more about Land And Improvements →
What does a Land And Improvements of €0 Mil mean?
Sartorius Stedim Biotech (CHIX:DIMP) has a Land And Improvements of €0 Mil as of Jun. 2026. Land and improvements records the total value of a company's land and improvements to it. View historical data on Sartorius Stedim Biotech and its competitors.
Is Sartorius Stedim Biotech's Land And Improvements too high?
Sartorius Stedim Biotech's current Land And Improvements is €0 Mil. Overall, Sartorius Stedim Biotech has a GF Score™ of 80/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Sartorius Stedim Biotech's Land And Improvements compare to ISRG and BDX?
Sartorius Stedim Biotech's Land And Improvements of €0 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Land And Improvements for a Medical Devices & Instruments company?
A good Land And Improvements depends on the Medical Devices & Instruments industry context. However, Land And Improvements should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Land And Improvements mean?
A high Land And Improvements can signal that a stock is expensive relative to its fundamentals. Land and improvements records the total value of a company's land and improvements to it. View historical data on Sartorius Stedim Biotech and its competitors. Sartorius Stedim Biotech's current Land And Improvements is €0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sartorius Stedim Biotech stock overvalued right now?
Based on GuruFocus' analysis, Sartorius Stedim Biotech (CHIX:DIMP) is currently considered Fairly Valued. The stock's GF Value™ is €202.60, compared to a current price of €193.00 — trading 4.7% below its estimated fair value. The current Land And Improvements is €0 Mil. Sartorius Stedim Biotech's overall GF Score™ is 80/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Land And Improvements calculated?
Land And Improvements is calculated from a company's financial statements. For Sartorius Stedim Biotech (CHIX:DIMP), the current Land And Improvements is €0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Sartorius Stedim Biotech (CHIX:DIMP) Overvalued in 2026?

Based on GuruFocus' analysis, Sartorius Stedim Biotech stock appears to be undervalued. The current stock price of €193.00 is trading 4.7% below its estimated GF Value™ of €202.60. GuruFocus considers Sartorius Stedim Biotech to be Fairly Valued.

Key valuation signals for CHIX:DIMP:

  • Land And Improvements: €0 Mil
  • GF Value™: €202.60 vs. price of €193.00 (4.7% below fair value)
  • GF Score™: 80/100 with 5 warning signs

No single metric tells the full story. See the CHIX:DIMP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Sartorius Stedim Biotech Business Description

Address Otto-Brenner-Strasse 20, Goettingen, DEU, 37079
Sartorius Stedim Biotech is a leading provider of bioprocessing solutions. It sells equipment and consumables for fermentation, filtration, fluid management, purification, and cell culture media for manufacturing biologic drugs and has a focus on single-use technology. It is a subsidiary of Sartorius AG, which has 71.5% ownership and 83% voting control. The business is geographically diverse, with 35% of sales from the Americas, 42% from Europe, the Middle East, and Africa, 15% from Asia excluding China, and 8% from China.
80GF Score

Get the complete analysis for CHIX:DIMP

Land And Improvements is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€193.00
Price
€202.60
GF Value